Differentiation of Carbapenemase producing Enterobacteriaceae by Triple disc Test

Background : Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity. They are often considered as last resort antibiotics in the treatment of infections due to multidrug-resistant organisms. Carbapenemase-producing Enterobacteriaceae (CPE) have been reported worldwide. Objective: Present study was carried out to differentiate Carbapenemase producing Enterobacteriaceae by Triple Disc Test (using meropenem, phenyl boronic acid and EDTA Discs) among various clinical isolates received in Department of Microbiology, SMS Medical College & attached Hospital, Jaipur. Methods: Carbapenemase producing meropenem resistant Enterobacteriaceae species isolated from clinical samples were included in the study. The study was designed for differentiation of KPC and MBL enzymes by using Triple Disk Tests consisting of meropenem alone and with phenylboronic acid (PBA), EDTA, or both PBA and EDTA Augmentation of the zone of inhibition by ≥5 mm was considered a positive combined-disc test result. Results: A total of 347 phenotypically confirmed carbapenemase-positive Enterobacteriaceae clinical isolates were examined. Out of these 194 strains were KPC producer, 102 strains were MBL producer and 51 strains were both KPC and MBL producers. Conclusions : This phenotypic method is very helpful to detect carbapenemase production and provides a simple algorithm for the differentiation of KPC and MBL enzymes, and guides in empirical treatment of patients especially in regions where KPCand MBL-possessing Enterobacteriaceae are highly prevalent.

[1]  J. Chander,et al.  Phenotypic method for differentiation of carbapenemases in Enterobacteriaceae: study from north India. , 2012, Indian journal of pathology & microbiology.

[2]  S. Kumari,et al.  Burden of different beta-lactamase classes among clinical isolates of AmpC-producing Pseudomonas aeruginosa in burn patients: A prospective study , 2012, Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine.

[3]  Thierry Naas,et al.  Global Spread of Carbapenemase-producing Enterobacteriaceae , 2011, Emerging infectious diseases.

[4]  N. Goel,et al.  Surveillance of multidrug resistant organisms in tertiary care hospital in Delhi, India. , 2010, The Journal of the Association of Physicians of India.

[5]  A. De,et al.  Prevalence of metallo-β-lactamase producing Pseudomonas aeruginosa and Acinetobacter species in intensive care areas in a tertiary care hospital , 2010, Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine.

[6]  S. Pournaras,et al.  A simple phenotypic method for the differentiation of metallo-beta-lactamases and class A KPC carbapenemases in Enterobacteriaceae clinical isolates. , 2010, The Journal of antimicrobial chemotherapy.

[7]  Kenneth S. Thomson,et al.  Extended-Spectrum-β-Lactamase, AmpC, and Carbapenemase Issues , 2010, Journal of Clinical Microbiology.

[8]  V. Miriagou,et al.  Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[9]  Yehuda Carmeli,et al.  Carbapenem-resistant Enterobacteriaceae: a potential threat. , 2008, JAMA.

[10]  A. Varaiya,et al.  Incidence of metallo-beta-lactamase-producing Pseudomonas aeruginosa in diabetes and cancer patients. , 2008, Indian journal of pathology & microbiology.

[11]  J. Patel,et al.  Evaluation of Methods To Identify the Klebsiella pneumoniae Carbapenemase in Enterobacteriaceae , 2007, Journal of Clinical Microbiology.

[12]  K. Bush,et al.  Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of Klebsiella pneumoniae , 2001, Antimicrobial Agents and Chemotherapy.

[13]  K. Bush,et al.  Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein , 1997, Antimicrobial agents and chemotherapy.

[14]  in chief George M. Garrity Bergey’s Manual® of Systematic Bacteriology , 1989, Springer New York.

[15]  M. T. Parker,et al.  Tests for the rapid breakdown of arginine by bacteria: their use in the identification of pseudomonads. , 1959, Journal of general microbiology.

[16]  U. Pennsylvania,et al.  Clinical and Laboratory Standards Institute , 2019, Springer Reference Medizin.

[17]  P. Wayne CLINICAL AND LABORATORY STANDARDS INSTITUTE. PERFORMANCE STANDARDS FOR ANTIMICROBIAL SUSCEPTIBILITY TESTING , 2011 .

[18]  G. Eliopoulos,et al.  The carbapenems: new broad spectrum β-lactam antibiotics , 1989 .